*Both authors contributed equally to this study. Capsule: A novel method was established to cryopreserve rare human spermatozoa. Three successful deliveries were achieved after transfer of blastocysts derived from the cryopreserved rare spermatozoa through intracytoplasmic sperm injection. 
INTRODUCTION
Male factor infertility is responsible for approximately 40-50% of fertility problems worldwide (Jackson et al., 2010) . The increasing occurrence of azoospermia and oligospermia seriously impairs male reproductive capacity (Carlsen et al., 1992) . Although it is possible to obtain spermatozoa from the patients with servere oligozoospermia by testicular spermatozoa extraction (TESE) or microsugical testicular sperm extraction (micro-TESE), well-preserving and efficient post-thawing the precious spermatozoa, even the single spermatozoa, is the main obstacle for successful pregnancy and delivery. Conventional spermatozoa freezing/thawing methods and devices may result in sperm loss during the process of repeated centrifugation and wash (Nawroth et al., 2002) . It is hard to apply to cryopreserve the rare spermatozoa. On the other side, repeated surgery procedures for diagnostic or therapeutic extraction will destroy the blood-testicular barrier and hurt their sexual function. Therefore, establishing a convenient and easy operating cryopreservation device and method is needed. Several cryopreservation methods have been reported in recent years; various containers and novel methodologies have been established to preserve the small numbers of spermatozoa (Cohen et al., 1997; Hsieh et al., 2000; Schuster et al., 2003; Vladimir et al., 2004; Herrler et al., 2006; Sereni et al., 2008; Chen et al., 2014) . Successful pregnancies have been reported through intracytoplasmic sperm injection (ICSI) with a few spermatozoa cryopreserved in empty zonapellucid (Walmsley et al., 1998; Fusi et al., 2001) . Most recently, Endo et al., (2012) reported a successful delivery after transfer of a blastocyst derived from ICSI using limited numbers of spermatozoa stored in cell sleeper, in spite of this they did not obtain motile spermatozoa after warming from cell sleeper and cryotop containers. Considering the potential risk of contamination and possible fertilization failure, it is urgent to develop a novel high-efficiency stored device and system.
In previous studies (Peng et al., 2011; Endo et al., 2012) , the devices cryostrip and cryoleaf have been developed to store the spermatozoa obtained from the patients with severe oligozoospermia. It is not practical and hard to find available. Therefore, we established a novel cryopiece system. In the present report, we make a brief introduction about this device and firstly report three successful deliveries using individual spermatozoa stored in cryopiece.
MATERIAL AND METHODS

Spermatozoa preparation
The liquefied ejaculated semen from the patients suffered with severe oligozoospermia were directly centrifuged at 500 g for 10 min. Removing the supernatant, 500 lL of floccule deposit was maintained on the bottom of conical centrifuge tube, then diluted and re-suspended with 3 mL modified human tubal fluid (mHTF, Irvine scientific, Santa Ana, CA, USA). After centrifugation for another 10 min, the maintained deposit was re-suspended again with 200 lL mHTF, the re-suspended deposit was then loaded on the micro-strips in the dish for single spermatozoa capture. The spermatozoa preparation procedure of the patients with non-obstructive azoospermia (NOA) was a bit of different with the above. Briefly, three 100 lL mHTF medium drops were firstly loaded on a 35 mm dish, the testicular tissue including seminiferous tubules by TESE or micro-TESE was added to the first drop, in turn changed to the second and third drop by glass pipette, the blood cells and other background were removed. Finally, it was dissected with two 1 mL-syringe needles in the third drop, the released testicular spermatozoa was collected by centrifugation at 500 g for 10 min, then loaded on the microstrips.
Spermatozoa capturing and establishment of cryopiece cryopreservation procedure
The cryopiece was designed for cryopreservation of single spermatozoa or small numbers of spermatozoa. The device and cryopreservation procedure are shown in Fig. 1 , the spermatozoa suspension was loaded into the microstrips in the dish covered with mineral oil (Fig. 1B) , cultured for 1 h until the spermatozoa moving to the margin of these strips. The spermatozoa with normal morphology and higher motility were captured under microscope using the ICSI pipettes equipped on the micromanipulator, then loaded on the indicated medium drops upon cryopiece (Fig. 1C) . After holding the piece upon liquid nitrogen vapor for 15 min, following putting it into a cell freezing tube and storing it in the liquid nitrogen tank (Fig. 1D ).
Rare spermatozoa thawing procedure
The 15 mL-tube (Falcon 352099, BD Biosciences, San Jose, CA, USA) contained with 5 mL mineral oil was cultured in 37°C incubator at least 1 h to heat the oil. Following, the cryopreserved cryopiece was pulled out from the freezing tube and placed at the bottom of a 35 cm dish (Falcon 351006, BD Biosciences, San Jose, CA, USA), and immediately covered with the pre-warmed mineral oil (Fig. 1E) . The thawed and recovered spermatozoa were prepared for ICSI.
Ovarian stimulation, ICSI, and pregnancy outcome
The female received stimulation treatment by rFSH (Gonal-F; Meck), HMG (HMG; Lizhu),GnRH antagonist (Cetrotide; Merck). Transvaginal sonography (TVS) guided follicular puncture was processed 36 h after the hCG (Mochida Pharmaceutical) injection. The harvested oocytes were denudated enzymatically with recombinant human hyaluronidase and mechanically by pipetting with commercial glass pipettes. The retrieved normal morphological spermatozoa were injected into the MII oocytes according to previous description (Greenblatt et al., 1995) . Fertilized embryos were cultured in G1plus medium (G1 plus; vitrolife) at 37 C in 6% CO 2 , 5% O 2 , and 89% N 2 . Embryo transfers were performed on day 3.
Biochemical pregnancy was confirmed by a positive b-human chorionic gonadotrophin (b-hCG) in blood or urine 2 weeks after embryo transfer. Ultrasound was performed at 6 weeks of gestation to confirm fetal viability. Clinical pregnancy was defined as the presence of a gestational sac in the uterine cavity detected by ultrasound at 4-6 weeks after transfer.
All the clinical information was obtained from the Reproductive Medicine Center, Shanghai General Hospital, Shanghai Jiaotong University and the clinical outcome analysis was approved by the Ethics Committee of Shanghai Jiao Tong University School of Medicine.
RESULT Case one
The 38-year-old male patient with non-obstructive azoospermia (NOA) received micro-TESE surgery, isolating seminiferous tubules and harvesting released spermatozoa were performed as mentioned in Materials and Method section. Only one or two spermatozoa were observed in five random low-power fields under microscope. A total of twenty motile and normal morphology spermatozoa were captured and loaded on the cryopreservation drops with ICSI pipettes, then stored in the tank with liquid nitrogen. All spermatozoa were thawed on the day of oocyte retrieval. Six mature (MII) oocytes were obtained from 10 cumulus-oocyte complexes. Eight of 18 (44.4%) spermatozoa were recovered with good forward motility and normal morphology, the rest was lost during the thawing procedure. Six spermatozoa were injected into the MII oocytes with ICSI, five of six (83%) normal zygotes were observed with two-pronuclear, following 100% cleaved, finally two excellent-quality embryo (8/II and 10/II) were transferred on day 3, which resulted in a singleton pregnancy and concluded with full-term delivery of a healthy boy (4800 g) at 36 weeks plus 1 day. All the information is summarized in Table 1 .
Case two
A 32-year-old male patient had been diagnosed with severe oligozoospermia. Cryopreserved forty motile spermatozoa from twice ejaculates were warmed. Thirty of 40 (75%) spermatozoa were recovered and 12 of them (40%) showed excellent motility. These spermatozoa were selected to inject into 11 matured oocytes from his spouse with ICSI. Eight of 11 oocytes (73%) were identified normal fertilization with two-pronuclear, following seven zygotes cleaved. Subsequently, two embryos were transferred back uterus on day 3, which resulted in twin live birth. Two healthy babies with bodyweights 2530 g (male) and 2700 g (female) were born after 33 weeks plus 3 days of pregnancy.
Case three
This case was a 26-year-old NOA male patient. Twenty-six motile spermatozoa by micro-TESE were cryopreserved with cryopiece. After thawing, 22 spermatozoa (10 motile and 12 Figure 1 The model of cryopiece-based freezing/thawing procedure. (A) Droplets and polypropylene piece of cryopiece system. (B) The cryopiece with culture medium droplets was putted into the bottom of the dish, the microstrips and another droplets were directly loaded on the dish, then covered with mineral oil. (C) The prepared rare spermatozoa sample was loaded on the microstrips, then the motile spermatozoa were captured and loaded on cryopiece ICSI pipettes, following stored in the liquid nitrogen tank (D). (E) The cryopiece with spermatozoa were inserted into the bottom of the dish, then covered with the pre-warmed mineral oil for thawing, the recovered spermatozoa were prepared for ICSI (F). [Colour figure can be viewed at wileyonlinelibrary.com].
834 Andrology, 2017, 5, 832-837 nonmotile) were found and four were lost. Eight spermatozoa with normal shape and motility were selected to be injected into eight MII oocytes. Normal fertilization was observed in five oocytes (63%), and four of the zygotes cleaved (80%). Two embryos were transferred back uterus on day 3 and failure pregnancy was tracked.
Case four
The patient was a 42-year-old male with NOA as a result of varicocoele (VC). Forty motile spermatozoa by micro-TESE were stored in two cryopieces. 18 spermatozoa in one cryopiece (six motile and 12 nonmotile) were recovered after thawing, then five MII oocytes were matched with five motile spermatozoa by ICSI. Following 80% fertilization rate and 75% cleavage rate were in turn observed. Two high quality embryos were transferred back uterus on day 2, which resulted in a singleton pregnancy and concluded with full-term delivery of a healthy boy (3100 g) at 37 weeks plus 4 days.
DISCUSSION
Our clinical outcome showed three successful deliveries of four pregnancies using limited numbers of cryopreserved spermatozoa stored in cryopiece from male patients suffered with NOA or oligozoospermia and no female sterility factor. This method will benefit to the couples with male infertility factor. Accumulated evidence documented various methods for successful cryopreservation of limited numbers of human spermatozoa, including empty zonapellucida (Cohen et al., 1997) , Volvoxglobator algae (Just et al., 2004) , cryoloops (Schuster et al., 2003; Desai et al., 2004) and agarose microspheres (Isaev et al., 2007) . To some extent, these devices could effectively save the rare spermatozoa and avoid multiple surgical procedures for spermatozoa extraction. However, widespread use of these devices in assisted reproduction laboratory was impeded because of various shortcomings, such as contamination and low recovered rate. Endo et al., (2012) reported that the higher fertilized rate (71%) and the successful delivery after ICSI using non-motile spermatozoa vitrified in cryotop and cell sleeper, they considered that the successful delivery contributed to oocyte activation with a calcium ionosphere. In this report, all warmed spermatozoa were immobilized by freezing. Thus, it is difficult to choose 'live' spermatozoa for ICSI. Moreover, the potential risk whether calcium ionophore activation has detrimental effects on embryonic development and children health is not clear. The introduction of empty zonapellucida for cryopreserving rare spermatozoa is an intriguing method, nevertheless, it depends on biologic materials from human or animal sources and the material is not easily available. In previous study, Peng et al., (2011) constructed a cryoleaf through heating a dish cover, this device could effectively cryopreserve individual or small numbers of human spermatozoa. In spite of this, we worry about that some chemical component released by heating the dish cover have side effect on spermatozoa. Therefore, we developed the novel cryopiece to avoid this potential risk. In this cryopiecebased freezing/thawing system, it could effectively cryopreserve limited number of spermatozoa without blood cells or testicular issue fragment contamination. In thawing procedure, a simple 37°Coil bath prevents from the spermatozoa loss. Most of spermatozoa were recovered within 10 min. Another advantage of this device is that it need not spend a long time to search 'live' spermatozoa for ICSI from the patients with NOA or oligozoospermia on the day of oocyte retrieval. It is well-known that spermatozoa harvested by micro-TESE are weaker than that from healthy male, most importantly, our cryopiece-based oil bath could maintain their motility as far as possible without repeated centrifugation in thawing procedure.
In our cryopiece-based system, it works well and is one of alternative small numbers of spermatozoa cyropreserved method successful in clinical application for severe male factor patients. Each patient enrolled in this clinical investigation has poor quality and very limited number of spermatozoa, only few spermatozoa show normal morphology and seem viable. A total of 126 spermatozoa obtained from four patients were cryopreserved individually in seven cryopiece. Eighty eight (83%) spermatozoa were recovered, among these recovered spermatozoa, 38 (36%) motile spermatozoa were selected in subsequent routine ICSI (Table 1) . Thirty MII mature oocytes in total 41 oocytes derived from the four patients' spouse. Following the ICSI, 73% fertilization and 86% zygotes cleaved were observed, then total 11 available embryos were obtained and each patient received two embryos transplantation. Up to now, a single live birth, a twin live birth, and a single live birth were tracked in case one, case two and case four, respectively (Table 2) . Although the warmed spermatozoa motility rate in cryopiece-based system is lower (36%) compared with vitrified in human or mouse zona (Hsieh et al., 2000; Levi-Setti et al., 2003) and volvoxglobator algae (Alexander et al., 2004) , our system exhibits a higher fertilized rate and good clinical outcome. Several reports have suggested the occurrence of cross-contamination during liquid nitrogen storage of biological material and subsequent cross-infection of patients (Tedder et al., 1995; Fountain et al., 1997) . On the contrary, Cobo et al. have not detected viral sequences after culture and vitrification of oocytes or embryos from HIV-, HBV-, and HCV-seropositive patients (Ana et al., 2012) . In spite of this, using safer storage devices is still a worthwhile strategy to avoid the hypothetical occurrence of cross-contamination (Cobo et al., 2010) . Considering this issue has been omitted in some cryopreservation methods, we designed the novel device to avoid the possible risk. As shown in Fig. 1 , the cryopiece loaded with spermatozoa was stored in a cell freezing tube, which prevents the direct contact between spermatozoa and liquid nitrogen. In addition, the cell freezing tube loaded spermatozoa was suspended in the liquid nitrogen vapor. Therefore, above factors effectively avoid the contamination.
It was stated that the ideal carrier for cryopreservation would allow the freezing of multiple tiny aliquots of spermatozoa or even individually isolated spermatozoa in small numbers (Abdelhafez et al., 2009) . Thus, furthermore investigations are required to design smaller volume droplet just for single spermatozoa to prevent wasting the invaluable spermatozoa. It is interesting that the nonmotile spermatozoa after thawing still maintains the fertilization ability without oocyte activation (Endo et al., 2012) . In our cryopiece-based system, we only choose the motile spermatozoa after thawing for ICSI, therefore, it is necessary in future study to test if the nonmotile warmed spermatozoa also have fertilization ability and developmental potency after ICSI.
In conclusion, this is a report about successful pregnancies using small numbers of spermatozoa stocked in effective and safe cryopiece system. In current report, only four cases were reported, more cases will be enrolled in future investigation to avoid the bias. Nevertheless, our clinical practice still supports that cryopiece system is a promising technique to cryopreserve rare spermatozoa.
